As of 2025-05-12, the EV/EBITDA ratio of VBI Vaccines Inc (VBIV) is -0.00. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. VBIV's latest enterprise value is 0.01 mil USD. VBIV's TTM EBITDA according to its financial statements is -45.59 mil USD. Dividing these 2 quantities gives us the above VBIV EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.9x - 13.3x | 11.1x |
| Forward P/E multiples | 19.1x - 33.0x | 26.0x |
| Fair Price | (5,686.51) - (3,959.72) | (5,530.20) |
| Upside | -8708383.3% - -6063983.1% | -8469019.5% |
| Date | EV/EBITDA |